Kane J M, Evans D L, Fiester S J, Mirin S M, Pincus H A, Schatzberg A F, Cole J O, Popper C W
J Clin Psychiatry. 1992 Jun;53(6):184-96.
This chapter includes a revision of psychopharmacological screening criteria originally developed in 1977-78 by the American Psychiatric Association (APA) and the National Institute of Mental Health (NIMH). This recent revision by the APA Committee on Research on Psychiatric Treatments provides criteria that are of considerable help in carrying out drug usage evaluations. Also included are useful suggestions for medical record documentation of specific classes of drugs, as well as for identification of adverse drug reactions. Thresholds for review are suggested.
本章包括对1977 - 1978年由美国精神病学协会（APA）和美国国立精神卫生研究所（NIMH）最初制定的精神药理学筛查标准的修订。APA精神科治疗研究委员会的此次最新修订提供了在进行药物使用评估时非常有帮助的标准。其中还包括关于特定类别药物病历记录以及药物不良反应识别的有用建议。文中还给出了审查阈值建议。
